Innovent Biologics Inc (6IB) — Working Capital to Net Assets Ratio
Innovent Biologics Inc (6IB) has a Working Capital to Net Assets ratio of 70.4% as of December 2025. Working capital of €13.63 Billion (current assets of €22.01 Billion minus current liabilities of €8.39 Billion) is measured against net assets of €19.36 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of Innovent Biologics Inc to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Innovent Biologics Inc Working Capital to Net Assets (2016–2025)
This chart shows how Innovent Biologics Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 70.4%, reflecting working capital of €13.63 Billion against net assets of €19.36 Billion EUR. See operational self-sufficiency of Innovent Biologics Inc to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Innovent Biologics Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Innovent Biologics Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Innovent Biologics Inc (6IB) total market value.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 70.4% | €13.63 Billion | €19.36 Billion | €22.01 Billion | €8.39 Billion | ▲ +25.4 pp |
| 2024 | 45.0% | €5.90 Billion | €13.12 Billion | €10.27 Billion | €4.37 Billion | ▼ -26.4 pp |
| 2023 | 71.5% | €8.95 Billion | €12.53 Billion | €13.43 Billion | €4.48 Billion | ▼ -3.2 pp |
| 2022 | 74.6% | €8.01 Billion | €10.73 Billion | €11.51 Billion | €3.50 Billion | ▼ -7.7 pp |
| 2021 | 82.3% | €8.50 Billion | €10.33 Billion | €11.55 Billion | €3.05 Billion | ▼ -8.6 pp |
| 2020 | 90.9% | €7.98 Billion | €8.78 Billion | €9.47 Billion | €1.49 Billion | ▼ -1.9 pp |
| 2019 | 92.8% | €4.41 Billion | €4.76 Billion | €5.46 Billion | €1.04 Billion | ▼ -3.0 pp |
| 2018 | 95.7% | €4.02 Billion | €4.19 Billion | €4.69 Billion | €670.32 Million | ▲ +174.8 pp |
| 2017 | -79.1% | €1.28 Billion | €-1.62 Billion | €1.45 Billion | €163.28 Million | ▲ +108.2 pp |
| 2016 | -187.3% | €1.79 Billion | €-958.22 Million | €1.87 Billion | €76.20 Million | — |